首页 > 最新文献

Jama-Journal of the American Medical Association最新文献

英文 中文
Impact of a Smartwatch Hypertension Notification Feature for Population Screening. 智能手表高血压通知功能对人群筛查的影响。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-09 DOI: 10.1001/jama.2025.26925
Jordana B Cohen, Daniel K Addo, Joshua A Jacobs, Tom H Greene, Yizhe Xu, Dean S Picone, Daichi Shimbo, Adam P Bress
{"title":"Impact of a Smartwatch Hypertension Notification Feature for Population Screening.","authors":"Jordana B Cohen, Daniel K Addo, Joshua A Jacobs, Tom H Greene, Yizhe Xu, Dean S Picone, Daichi Shimbo, Adam P Bress","doi":"10.1001/jama.2025.26925","DOIUrl":"https://doi.org/10.1001/jama.2025.26925","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cesarean Delivery on Maternal Request. 应产妇要求剖宫产。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-09 DOI: 10.1001/jama.2025.26633
Marianna Alperin, Amanda Artsen
{"title":"Cesarean Delivery on Maternal Request.","authors":"Marianna Alperin, Amanda Artsen","doi":"10.1001/jama.2025.26633","DOIUrl":"https://doi.org/10.1001/jama.2025.26633","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting -Reply. 确定冠状动脉搭桥术后新发房颤的口服抗凝治疗时间——答复。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-09 DOI: 10.1001/jama.2025.25371
Florian E M Herrmann, Anders Jeppsson, Christian Hagl
{"title":"Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting -Reply.","authors":"Florian E M Herrmann, Anders Jeppsson, Christian Hagl","doi":"10.1001/jama.2025.25371","DOIUrl":"https://doi.org/10.1001/jama.2025.25371","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting. 确定冠状动脉搭桥术后新发房颤的口服抗凝治疗时间。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-09 DOI: 10.1001/jama.2025.25368
Can Xu, Jason Zhensheng Qu, Dongjin Wang
{"title":"Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting.","authors":"Can Xu, Jason Zhensheng Qu, Dongjin Wang","doi":"10.1001/jama.2025.25368","DOIUrl":"https://doi.org/10.1001/jama.2025.25368","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coffee and Tea Intake, Dementia Risk, and Cognitive Function. 咖啡和茶的摄入量,痴呆风险和认知功能。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-09 DOI: 10.1001/jama.2025.27259
Yu Zhang, Yuxi Liu, Yanping Li, Yuhan Li, Xiao Gu, Jae H Kang, A Heather Eliassen, Molin Wang, Eric B Rimm, Walter C Willett, Frank B Hu, Meir J Stampfer, Dong D Wang
<p><strong>Importance: </strong>Evidence linking coffee and tea to cognitive health remains inconclusive, and most studies fail to differentiate caffeinated from decaffeinated coffee.</p><p><strong>Objective: </strong>To investigate associations of coffee and tea intake with dementia risk and cognitive function.</p><p><strong>Design, setting, and participants: </strong>Prospective cohort study that included female participants from the Nurses' Health Study (NHS; n = 86 606 with data from 1980-2023) and male participants from the Health Professionals Follow-up Study (HPFS; n = 45 215 with data from 1986-2023) who did not have cancer, Parkinson disease, or dementia at study entry (baseline) in the US.</p><p><strong>Exposures: </strong>The primary exposures were intakes of caffeinated coffee, decaffeinated coffee, and tea. Dietary intake was collected every 2 to 4 years using validated food frequency questionnaires.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was dementia, which was identified via death records and physician diagnoses. The secondary outcomes included subjective cognitive decline assessed by a questionnaire-based score (range, 0-7; higher scores indicate greater perceived decline; cases defined as those with a score ≥3) and objective cognitive function assessed only in the NHS cohort using telephone-based neuropsychological tests such as the Telephone Interview for Cognitive Status (TICS) score (range, 0-41) and a measure of global cognition (a standardized mean z score for all 6 administered cognitive tests).</p><p><strong>Results: </strong>Among 131 821 participants (mean age at baseline, 46.2 [SD, 7.2] years in the NHS cohort and 53.8 [SD, 9.7] years in the HPFS cohort; 65.7% were female) during up to 43 years of follow-up (median, 36.8 years; IQR, 28-42 years), there were 11 033 cases of incident dementia. After adjusting for potential confounders and pooling results across cohorts, higher caffeinated coffee intake was significantly associated with lower dementia risk (141 vs 330 cases per 100 000 person-years comparing the fourth [highest] quartile of consumption with the first [lowest] quartile; hazard ratio, 0.82 [95% CI, 0.76 to 0.89]) and lower prevalence of subjective cognitive decline (7.8% vs 9.5%, respectively; prevalence ratio, 0.85 [95% CI, 0.78 to 0.93]). In the NHS cohort, higher caffeinated coffee intake was also associated with better objective cognitive performance. Compared with participants in the lowest quartile, those in the highest quartile had a higher mean TICS score (mean difference, 0.11 [95% CI, 0.01 to 0.21]) and a higher mean global cognition score (mean difference, 0.02 [95% CI, -0.01 to 0.04]); however, the association with global cognition was not statistically significant (P = .06). Higher intake of tea showed similar associations with these cognitive outcomes, whereas decaffeinated coffee intake was not associated with lower dementia risk or better cognitive performance.
重要性:将咖啡和茶与认知健康联系起来的证据仍然没有定论,而且大多数研究未能区分含咖啡因和不含咖啡因的咖啡。目的:探讨咖啡和茶摄入量与痴呆风险和认知功能的关系。设计、环境和参与者:前瞻性队列研究包括来自护士健康研究(NHS; n = 86 606,数据来自1980-2023)的女性参与者和来自卫生专业人员随访研究(HPFS; n = 45 215,数据来自1986-2023)的男性参与者,他们在研究开始时(基线)在美国没有癌症、帕金森病或痴呆。暴露:主要暴露是摄入含咖啡因的咖啡、不含咖啡因的咖啡和茶。通过有效的食物频率问卷每2至4年收集一次膳食摄入量。主要结局和测量:主要结局是痴呆,通过死亡记录和医生诊断确定。次要结局包括主观认知能力下降,通过基于问卷的评分评估(范围,0-7;得分越高表明感知能力下降越严重;病例定义为得分≥3),客观认知功能仅在NHS队列中使用基于电话的神经心理测试评估,如认知状态电话访谈(TICS)评分(范围,0-41)和全球认知测量(所有6个给予的认知测试的标准化平均z分数)。结果:131 821名参与者(NHS队列的平均基线年龄为46.2 [SD, 7.2]岁,HPFS队列的平均年龄为53.8 [SD, 9.7]岁,65.7%为女性)在长达43年的随访期间(中位数为36.8岁;IQR为28-42岁),有11 033例发生痴呆。在调整了潜在的混杂因素和跨队列的汇总结果后,高含咖啡因的咖啡摄入量与较低的痴呆风险显著相关(第四个[最高]四分位数与第一个[最低]四分位数比较,每100 000人中有141例对330例;风险比为0.82 [95% CI, 0.76至0.89])和较低的主观认知能力下降患病率(分别为7.8%对9.5%;患病率为0.85 [95% CI, 0.78至0.93])。在NHS队列中,高含咖啡因的咖啡摄入量也与更好的客观认知表现有关。与最低四分位数的参与者相比,最高四分位数的参与者具有更高的平均TICS评分(平均差值为0.11 [95% CI, 0.01至0.21])和更高的平均全局认知评分(平均差值为0.02 [95% CI, -0.01至0.04]);然而,与整体认知的关联无统计学意义(P = .06)。摄入更多的茶与这些认知结果显示出类似的关联,而摄入不含咖啡因的咖啡与降低痴呆风险或改善认知表现没有关联。一项剂量-反应分析显示,含咖啡因的咖啡和茶的摄入量与痴呆风险和主观认知能力下降呈非线性负相关。最明显的相关差异是每天摄入大约2到3杯含咖啡因的咖啡或每天摄入1到2杯茶。结论和相关性:大量饮用含咖啡因的咖啡和茶与较低的痴呆风险和适度改善的认知功能相关,在适量摄入时相关性最明显。
{"title":"Coffee and Tea Intake, Dementia Risk, and Cognitive Function.","authors":"Yu Zhang, Yuxi Liu, Yanping Li, Yuhan Li, Xiao Gu, Jae H Kang, A Heather Eliassen, Molin Wang, Eric B Rimm, Walter C Willett, Frank B Hu, Meir J Stampfer, Dong D Wang","doi":"10.1001/jama.2025.27259","DOIUrl":"https://doi.org/10.1001/jama.2025.27259","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Evidence linking coffee and tea to cognitive health remains inconclusive, and most studies fail to differentiate caffeinated from decaffeinated coffee.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate associations of coffee and tea intake with dementia risk and cognitive function.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;Prospective cohort study that included female participants from the Nurses' Health Study (NHS; n = 86 606 with data from 1980-2023) and male participants from the Health Professionals Follow-up Study (HPFS; n = 45 215 with data from 1986-2023) who did not have cancer, Parkinson disease, or dementia at study entry (baseline) in the US.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposures: &lt;/strong&gt;The primary exposures were intakes of caffeinated coffee, decaffeinated coffee, and tea. Dietary intake was collected every 2 to 4 years using validated food frequency questionnaires.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;The primary outcome was dementia, which was identified via death records and physician diagnoses. The secondary outcomes included subjective cognitive decline assessed by a questionnaire-based score (range, 0-7; higher scores indicate greater perceived decline; cases defined as those with a score ≥3) and objective cognitive function assessed only in the NHS cohort using telephone-based neuropsychological tests such as the Telephone Interview for Cognitive Status (TICS) score (range, 0-41) and a measure of global cognition (a standardized mean z score for all 6 administered cognitive tests).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among 131 821 participants (mean age at baseline, 46.2 [SD, 7.2] years in the NHS cohort and 53.8 [SD, 9.7] years in the HPFS cohort; 65.7% were female) during up to 43 years of follow-up (median, 36.8 years; IQR, 28-42 years), there were 11 033 cases of incident dementia. After adjusting for potential confounders and pooling results across cohorts, higher caffeinated coffee intake was significantly associated with lower dementia risk (141 vs 330 cases per 100 000 person-years comparing the fourth [highest] quartile of consumption with the first [lowest] quartile; hazard ratio, 0.82 [95% CI, 0.76 to 0.89]) and lower prevalence of subjective cognitive decline (7.8% vs 9.5%, respectively; prevalence ratio, 0.85 [95% CI, 0.78 to 0.93]). In the NHS cohort, higher caffeinated coffee intake was also associated with better objective cognitive performance. Compared with participants in the lowest quartile, those in the highest quartile had a higher mean TICS score (mean difference, 0.11 [95% CI, 0.01 to 0.21]) and a higher mean global cognition score (mean difference, 0.02 [95% CI, -0.01 to 0.04]); however, the association with global cognition was not statistically significant (P = .06). Higher intake of tea showed similar associations with these cognitive outcomes, whereas decaffeinated coffee intake was not associated with lower dementia risk or better cognitive performance.","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aluminum Exposure From Vaccines and Diet. 从疫苗和饮食中接触铝
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-09 DOI: 10.1001/jama.2026.0056
Charlotte A Moser, Paul A Offit
{"title":"Aluminum Exposure From Vaccines and Diet.","authors":"Charlotte A Moser, Paul A Offit","doi":"10.1001/jama.2026.0056","DOIUrl":"https://doi.org/10.1001/jama.2026.0056","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Geroscience-Reply. 地球科学述评[j]。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-03 DOI: 10.1001/jama.2025.21378
Stephen B Kritchevsky, Steven R Cummings
{"title":"A Review of Geroscience-Reply.","authors":"Stephen B Kritchevsky, Steven R Cummings","doi":"10.1001/jama.2025.21378","DOIUrl":"10.1001/jama.2025.21378","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"461"},"PeriodicalIF":55.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Geroscience. 地质科学综述。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-03 DOI: 10.1001/jama.2025.21376
Frederick M Hecht
{"title":"A Review of Geroscience.","authors":"Frederick M Hecht","doi":"10.1001/jama.2025.21376","DOIUrl":"10.1001/jama.2025.21376","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"460-461"},"PeriodicalIF":55.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
My New Neurologist. 我的新神经科医生。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-03 DOI: 10.1001/jama.2025.21940
Abigail Zuger
{"title":"My New Neurologist.","authors":"Abigail Zuger","doi":"10.1001/jama.2025.21940","DOIUrl":"https://doi.org/10.1001/jama.2025.21940","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":"335 5","pages":"465"},"PeriodicalIF":55.0,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Call for Education Leadership in Accreditation Reform. 呼吁教育领导认证改革。
IF 55 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1001/jama.2025.27095
David T Stern, Monica L Lypson, Frederic W Hafferty
{"title":"A Call for Education Leadership in Accreditation Reform.","authors":"David T Stern, Monica L Lypson, Frederic W Hafferty","doi":"10.1001/jama.2025.27095","DOIUrl":"https://doi.org/10.1001/jama.2025.27095","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":55.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jama-Journal of the American Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1